{"brief_title": "Aripiprazole in Patients With Acute Mania", "brief_summary": "The purpose of this trial is to test the safety & efficacy of aripiprazole in patients with Bipolar Mania for a period of at least 12 weeks.", "condition": "Bipolar Disorder", "intervention_type": "Drug", "intervention_name": "aripiprazole", "criteria": "Inclusion Criteria: - Primary diagnosis of Acute Bipolar I Mania Exclusion Criteria: - Patients with a DSM-IV diagnosis other than Bipolar I Mania", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00095511.xml"}